Champions Oncology (CSBR) Reports Q3 Loss of $0.21/Share

March 15, 2016 8:49 AM EDT

Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of ($0.21), versus ($0.49) reported last year. Revenue for the quarter came in at $2.6 million, versus $1.8 million reported last year.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings